In vivo activity of cationic immune stimulating complexes (PLUSCOMs)MCBURNEY, Warren T; LENDEMANS, Dirk G; MYSCHIK, Julia et al.Vaccine. 2008, Vol 26, Num 35, pp 4549-4556, issn 0264-410X, 8 p.Article

Cage-like complexes formed by DOTAP, Quil-A and cholesterolLENDEMANS, D. G; EGERT, A. M; HOOK, S et al.International journal of pharmaceutics. 2007, Vol 332, Num 1-2, pp 192-195, issn 0378-5173, 4 p.Article

Synthesis of cationic derivatives of Quil A and the preparation of cationic immune-stimulating complexes (ISCOMs)PHAM, Hoang L; ROSS, Benjamin P; MCGEARY, Ross P et al.International journal of pharmaceutics (Print). 2009, Vol 376, Num 1-2, pp 123-133, issn 0378-5173, 11 p.Article

ISCOMs and immunostimulation with viral antigensHOGLUND, S; DALSGAARD, K; LOVGREN, K et al.Sub-cellular Biochemistry. 1989, Vol 15, pp 39-68, issn 0096-8757Article

Evaluation of ISCOMATRIX™ and ISCOM™ vaccines for immunisation against Helicobacter pyloriSKENE, Caroline D; DOIDGE, Christopher; SUTTON, Philip et al.Vaccine. 2008, Vol 26, Num 31, pp 3880-3884, issn 0264-410X, 5 p.Article

Induction of protective and mucosal immunity against diphtheria by a immune stimulating complex (ISCOMS) based vaccineAGUILA, Antonio; DONACHIE, Anne M; PEYRE, Marisa et al.Vaccine. 2006, Vol 24, Num 24, pp 5201-5210, issn 0264-410X, 10 p.Article

Bovine respiratory syncytial virus ISCOMs: protection in the presence of maternal antibodiesHÄGGLUND, Sara; HU, Ke-Fei; LARSEN, Lars Erik et al.Vaccine. 2004, Vol 23, Num 5, pp 646-655, issn 0264-410X, 10 p.Article

ISCOMATRIX adjuvant: a potent inducer of humoral and cellular immune responsesPEARSE, M. J; DRANE, D.Vaccine. 2004, Vol 22, Num 19, pp 2391-2395, issn 0264-410X, 5 p.Conference Paper

Immunogenicity and protective effect against murine cerebral neosporosis of recombinant NcSRS2 in different iscom formulationsPINITKIATISAKUL, Sunan; FRIEDMAN, Mikaela; WIKMAN, Maria et al.Vaccine. 2007, Vol 25, Num 18, pp 3658-3668, issn 0264-410X, 11 p.Article

Cytotoxic T cell polyepitope vaccines delivered by ISCOMsLE, Thuy T. T; DRANE, Debbie; MALLIAROS, Jim et al.Vaccine. 2001, Vol 19, Num 32, pp 4669-4675, issn 0264-410XArticle

A single dose of an ISCOM influenza vaccine induces long-lasting protective immunity against homologous challenge infection but fails to protect Cynomolgus macaques against distant drift variants of influenza A (H3N2) virusesRIMMELZWAAN, G. F; BAARS, M; VAN AMERONGEN, G et al.Vaccine. 2001, Vol 20, Num 1-2, pp 158-163, issn 0264-410XArticle

Liposomes and ISCOMsKERSTEN, Gideon F. A; CROMMELIN, Daan J. A.Vaccine. 2003, Vol 21, Num 9-10, pp 915-920, issn 0264-410X, 6 p.Conference Paper

ISCOMATRIX® adjuvant for antigen deliveryPEARSE, Martin J; DRANE, Debbie.Advanced drug delivery reviews. 2005, Vol 57, Num 3, pp 465-474, issn 0169-409X, 10 p.Article

The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gapHELDENS, J. G. M; POUWELS, H. G. W; DERKS, C. G. G et al.Vaccine. 2009, Vol 27, Num 40, pp 5530-5537, issn 0264-410X, 8 p.Article

Evaluation of ISCOM-adjuvanted subunit vaccines containing recombinant feline immunodeficiency virus Rev, OrfA and envelope protein in catsHUISMAN, Willem; SCHRAUWEN, Eefje J. A; PAS, Suzan D et al.Vaccine. 2008, Vol 26, Num 21, pp 2553-2561, issn 0264-410X, 9 p.Article

Safety and efficacy of immune-stimulating complex-based antigen delivery systems for neonatal immunisation against respiratory syncytial virus infectionREGNER, Matthias; CULLEY, Fiona; FONTANNAZ, Paola et al.Microbes and infection. 2004, Vol 6, Num 7, pp 666-675, issn 1286-4579, 10 p.Article

Association of antigens to ISCOMATRIX adjuvant using metal chelation leads to improved CTL responsesMALLIAROS, Jim; QUINN, Charles; ARNOLD, Frances H et al.Vaccine. 2004, Vol 22, Num 29-30, pp 3968-3975, issn 0264-410X, 8 p.Article

Cationic cage-like complexes formed by DC-cholesterol, Quil-A, and phospholipidLENDEMANS, Dirk G; MYSCHIK, Julia; HOOK, Sarah et al.Journal of pharmaceutical sciences. 2005, Vol 94, Num 8, pp 1794-1807, issn 0022-3549, 14 p.Article

VLPs and particle strategies for cancer vaccinesUNGARO, Francesca; CONTE, Claudia; QUAGLIA, Fabiana et al.Expert review of vaccines. 2013, Vol 12, Num 10, pp 1173-1193, issn 1476-0584, 21 p.Article

Evaluation of ISCOM vaccines for mucosal immunization against hepatitis BPANDEY, R. S; DIXIT, V. K.Journal of drug targeting. 2010, Vol 18, Num 4, pp 282-291, issn 1061-186X, 10 p.Article

Rinderpest virus (RPV) ISCOM vaccine induces protection in cattle against virulent RPV challengeKAMATA, Hiroshi; OHISHI, Kazue; HULSKOTTE, Ellena et al.Vaccine. 2001, Vol 19, Num 25-26, pp 3355-3359, issn 0264-410XArticle

Mannosylated saponins based on oleanolic and glycyrrhizic acids. Towards synthetic colloidal antigen delivery systemsDAINES, Alison M; GREATREX, Ben W; HAYMAN, Colin M et al.Bioorganic & medicinal chemistry. 2009, Vol 17, Num 14, pp 5207-5218, issn 0968-0896, 12 p.Article

A novel method for preparing immune stimulating complexes (ISCOMs) by hydration of freeze-dried lipid matrixMINGTAO LIANG; TOTH, Istvan; DAVIES, Nigel M et al.European journal of pharmaceutics and biopharmaceutics. 2008, Vol 68, Num 3, pp 840-845, issn 0939-6411, 6 p.Article

Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccineANGELOS, John A; HESS, John F; GEORGE, Lisle W et al.Vaccine. 2004, Vol 23, Num 4, pp 537-545, issn 0264-410X, 9 p.Article

The iscom : an antigen delivery system with built-in adjuvantLOVGREN, K; MOREIN, B.Molecular immunology. 1991, Vol 28, Num 3, pp 285-286, issn 0161-5890Conference Paper